SHL Medical returns to Shanghai for CPHI and PMEC China 2026

Bringing combination products to China and the APAC region requires local insight and the flexibility to adapt device solutions to evolving market needs. 

Taking place June 16–18 in Shanghai, CPHI and PMEC China 2026 brings together global and local stakeholders across the drug delivery value chain to address these concerns. SHL Medical will join this platform to engage with industry peers on how innovation can be effectively translated into the China market and beyond. 

At Booth #N5F28, we will showcase our device portfolio, including Reunite, our dual-chamber cartridge autoinjector for lyophilized drug delivery, Maggie, our large-volume cartridge-based autoinjector, and Molly, our proven modular platform with established manufacturing and scale-up capabilities. 

With our global manufacturing network and growing presence in China, we support pharma and biotech partners in delivering solutions designed for scalability and local market alignment. 

Visit us at Booth #N5F28 to discuss strategies for advancing drug delivery programs in China and across APAC.